Natural environments may cut hospitalization for patients with neurodegenerative diseases
Dec 30, 2022
The normalized difference vegetation index was negatively associated with hospitalization for Alzheimer’s disease and related dementia as well as Parkinson’s disease.
Healthier lifestyle linked to better global cognition close to death
Feb 06, 2024
Neither the strength nor the significance of the association was changed when common dementia-related brain pathologies were included in the model.
Risks for neurologic, psychiatric sequelae persist after COVID-19
Sep 02, 2022
Adults have increased risks for cognitive deficit, dementia, psychotic disorders, epilepsy or seizures at two-year follow-up.
Alzheimer’s disease, related dementia diagnoses up in Medicare decedents
Apr 01, 2022
The percentage of older U.S. decedents with a diagnosis of Alzheimer’s disease and related dementias increased significantly from 2004 to 2017.
Risk for decline up for low-income seniors after ICU stay
Mar 08, 2022
The risks for disability and transition to probable dementia increased after an ICU stay for seniors with dual eligibility for Medicare and Medicaid.
Variation in total cholesterol, triglycerides linked to Alzheimer’s disease risk
Jul 06, 2023
Those in the highest quintile of total cholesterol and triglycerides had increased risk for Alzheimer’s disease and Alzheimer’s-related dementias.
American Academy of Neurology, April 13-18
Apr 23, 2024
The annual meeting of the American Academy of Neurology was held this year from April 13 to 18 in Denver, drawing participants from around the world, including clinicians, academicians, allied health professionals,...
Heart attack survivorship tied to long-term health consequences
Mar 04, 2024
An increased risk was seen for atrial fibrillation and cerebrovascular disease, among others.
Cognitive impairment delayed with genetic variant
Jun 20, 2024
The onset of cognitive impairment was delayed among those heterozygous for the apolipoprotein E3 Christchurch variant.
DMARDs not linked to Alzheimer’s risk for seniors with RA
Apr 12, 2022
No reduction in the risk for Alzheimer’s disease and related dementia was seen with treatment with tofacitinib, tocilizumab or tumor necrosis factor inhibitors versus abatacept.